Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

World’s Leading PTR-MS Company IONICON Integrates its Subsidiary

Published: Friday, June 07, 2013
Last Updated: Friday, June 07, 2013
Bookmark and Share
IONICON to celebrate its 15th anniversary in July 2013.

IONICON has integrated its subsidiary company IONIMED Analytik Ges.m.b.H. The company now offers solutions for a broad range of markets.

Among them traditional strong fields such as environmental research, food & flavor science but also medical and biotechnological process monitoring applications.

IONICON CEO Lukas MÄRK welcomes the strategically important milestone in the company’s history: “The integration of both companies is a huge step forward and lets us capitalize on synergies. The joint forces of our teams have enormous potential for product development and market diversification.”

Customers can now benefit from ultra-sensitive real-time trace gas analyzers, advanced calibration devices, customized solutions and analytical services now being provided by over 30 experts pulling in the same direction.

“IONIMED” is now an IONICON Analytik GmbH brand.

IONICON manufactures ultra-sensitive real-time trace gas analyzers using the unique Proton Transfer Reaction - Mass Spectrometry (PTR-MS) and proprietary Selective Reagent Ionization - Mass Spectrometry (SRI-MS) technology.

PTR-MS, when launched in 1998 revolutionized direct and online analysis of volatile organic compounds (VOCs). Before that cost and time consuming chemical methods were applied that did not provide such a high time-resolution or sensitivity.

Therefore over 200 leading scientists, institutions and multinational corporations are among IONICON’s customers relying on VOC monitoring and quantification instruments.

In July 2013 IONICON will celebrate its 15th anniversary with many innovations coming up.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Thursday, August 20, 2015
IONICON Selects RJ Lee Group as Exclusive U.S. Distributor
RJ Lee Group has become the exclusive U.S. distribution partner for IONICON’s Trace Gas Analysis products.
Thursday, June 27, 2013
RJ Lee Group's Mobile Lab is Now Deployed for Real-Time VOCs Monitoring
RJ Lee Group equipes mobile lab with IONICON PTR-MS and provides rapid, mobile monitoring of organic contamination and leaks caused by hurricane "Sandy".
Thursday, November 15, 2012
IONICON Announces New Distribution Partner for Australia and New Zealand
IONICON and Ecotech are teaming up.
Wednesday, August 22, 2012
IONICON Announces New Distribution Partner for Singapore, Malaysia and Thailand
IONICON and Omega join efforts in Southeast Asia.
Monday, April 30, 2012
IONICON US Starts its Operations in North America
Effective and fast local PTR-MS sales and support for US customers now directly available from IONICON US, Inc., New Jersey.
Thursday, October 20, 2011
First Results of CERN's CLOUD Experiment Published in NATURE
The CLOUD experiment has been designed to study the effect of cosmic rays on the formation of atmospheric aerosols under controlled laboratory conditions.
Thursday, August 25, 2011
IONICON Announces New Distribution Partner for India
IONICON and MARS Bioanalytical have teamed up to target the Indian market.
Sunday, July 24, 2011
IONICON Appoints New CEO
Mr. Lukas MÄRK stepped in as CEO IONICON Analytik GmbH on June 1, 2011.
Monday, July 11, 2011
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos